In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 26th, 2005 | 24 | Yes |
Popular Name: Ciprofloxacin Ciprofloxacin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 85721-33-1 , 86393-32-0 , 86483-48-9 , 93107-08-5 , 97867-33-9 , [86393-32-0] , [86483-48-9] , [93107-08-5]
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4 -dihydro-3-quinolinecarboxylic acid hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 2-hydroxypropanoic acid
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid; 2-hydroxypropanoic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
85721-33-1; C05349; Ciprofloxacin
93107-08-5; Ciprofloxacin hydrochloride; Prestwick_67
97867-33-9; Ciprofloxacin lactate; Ciproxin (TN); D07702
BAY-Q-3939; BAY-O-9867 Monohydrate; BAY-O-9867
BAY-Q-3939; BAY-O-9867; BAY-O-9867 Monohydrate
CHEBI:41638; CHEBI:3717; CHEBI:102718
ciprofloxacin hydrochloride hydrate
Ciprofloxacin hydrochloride monohydrate
Ciprofloxacin monohydrochloride
Ciprofloxacin monohydrochloride;Ciprofloxacina
Ciprofloxacin, Ciprofloxacin Hydrochloride
CIPROFLOXACIN; CIPROFLOXACIN EXTENDED RELEASE; CIPROFLOXACIN HYDROCHLORIDE; LS-187906
ciprofloxacin; ciprofloxacine; ciprofloxacino; ciprofloxacinum
CYCLOPROPYLFLUOROOXOPIPERAZINYLDIHYDROQUINOLINECARBOXYLICACIDHYDROCHLORID
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.70 | 9.07 | -109.14 | 2 | 6 | 0 | 82 | 331.347 | 3 | ↓ |
Hi High (pH 8-9.5) | -0.70 | 7.77 | -65.4 | 1 | 6 | -1 | 77 | 330.339 | 3 | ↓ |
Mid Mid (pH 6-8) | -3.45 | 7.06 | -88.49 | 3 | 6 | 1 | 85 | 332.355 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Molecular_Solubility | 2.401 | Bitter DB |
biological_use | . | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 1.35e+00 g/l | DrugBank-approved |
MP | 271 - 273 | Enamine Building Blocks |
MP | 271...273 | Enamine Building Blocks |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 95% | Fluorochem |
Purity | 96% | Fluorochem |
Therapy | antibacterial, fungicide | SMDC Pharmakon |
Indications | antibiotic | KeyOrganics Bioactives |
biological_use | Broad spectrum antibacterial agent (used in treatment of Legionnaire's disease) | IBScreen Bioactives IBScreen Bioactives |
Indications | broad-spectrum antibiotic | KeyOrganics Bioactives |
mechanism | DNA gyrase (type II topoisomerase) and topoisomerase IV inhibitor | IBScreen Bioactives |
UniProt Database Links | FLQE1_MYCTU; FLQE2_MYCTU; FLQE3_MYCTU; GYRA_STAA3; MDTK_ECOLI; MEPA_STAA8; NORB_STAA8; NORM_VIBCH; NORM_VIBPA; SBCC_STAA8; SBCC_STAAE; SBCD_STAA8; SBCD_STAAE | ChEBI |
Warnings | IRRITANT | Matrix Scientific |
Target | Others | Selleck Chemicals |
biological_use | Provides postexposure protection against exp. inhalation anthrax ( Bacillus anthracis ) | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GYRA-1-B | DNA Gyrase Subunit A (cluster #1 Of 1), Bacterial | Bacteria | 500 | 0.37 | Binding ≤ 10μM |
GYRB-1-B | DNA Gyrase Subunit B (cluster #1 Of 1), Bacterial | Bacteria | 500 | 0.37 | Binding ≤ 10μM |
PARC-1-B | Topoisomerase IV Subunit A (cluster #1 Of 1), Bacterial | Bacteria | 2300 | 0.33 | Binding ≤ 10μM |
GYRA-1-B | DNA Gyrase Subunit A (cluster #1 Of 1), Bacterial | Bacteria | 200 | 0.39 | Functional ≤ 10μM |
GYRB-1-B | DNA Gyrase Subunit B (cluster #1 Of 1), Bacterial | Bacteria | 200 | 0.39 | Functional ≤ 10μM |
PARC-1-B | Topoisomerase IV Subunit A (cluster #1 Of 1), Bacterial | Bacteria | 2500 | 0.33 | Functional ≤ 10μM |
KCNH2-1-E | HERG (cluster #1 Of 5), Eukaryotic | Eukaryotes | 3020 | 0.32 | Binding ≤ 10μM |
TOP2A-1-E | DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 30 | 0.44 | Binding ≤ 10μM |
TOP2B-1-E | DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 30 | 0.44 | Binding ≤ 10μM |
Z104301-1-O | GABA-A Receptor; Anion Channel (cluster #1 Of 8), Other | Other | 410 | 0.37 | Binding ≤ 10μM |
Z50117-1-O | Pseudomonas Aeruginosa (cluster #1 Of 2), Other | Other | 220 | 0.39 | Functional ≤ 10μM |
Z50185-3-O | Staphylococcus Aureus (cluster #3 Of 4), Other | Other | 400 | 0.37 | Functional ≤ 10μM |
Z50212-1-O | Escherichia Coli (cluster #1 Of 7), Other | Other | 10 | 0.47 | Functional ≤ 10μM |
Z50378-1-O | Mycobacterium Intracellulare (cluster #1 Of 1), Other | Other | 910 | 0.35 | Functional ≤ 10μM |
Z50380-1-O | Mycobacterium Smegmatis (cluster #1 Of 4), Other | Other | 1980 | 0.33 | Functional ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 9440 | 0.29 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GYRA_ECOLI | P0AES4 | DNA Gyrase Subunit A, Ecoli | 300 | 0.38 | Binding ≤ 1μM |
GYRB_ECOLI | P0AES6 | DNA Gyrase Subunit B, Ecoli | 300 | 0.38 | Binding ≤ 1μM |
TOP2A_HUMAN | P11388 | DNA Topoisomerase II Alpha, Human | 30 | 0.44 | Binding ≤ 1μM |
TOP2B_HUMAN | Q02880 | DNA Topoisomerase II Beta, Human | 30 | 0.44 | Binding ≤ 1μM |
Z104301 | Z104301 | GABA-A Receptor; Anion Channel | 410 | 0.37 | Binding ≤ 1μM |
PARC_STAAU | P0C1U9 | Topoisomerase IV Subunit A, Staau | 1000 | 0.35 | Binding ≤ 1μM |
GYRA_ECOLI | P0AES4 | DNA Gyrase Subunit A, Ecoli | 300 | 0.38 | Binding ≤ 10μM |
GYRB_ECOLI | P0AES6 | DNA Gyrase Subunit B, Ecoli | 300 | 0.38 | Binding ≤ 10μM |
TOP2A_HUMAN | P11388 | DNA Topoisomerase II Alpha, Human | 30 | 0.44 | Binding ≤ 10μM |
TOP2B_HUMAN | Q02880 | DNA Topoisomerase II Beta, Human | 30 | 0.44 | Binding ≤ 10μM |
Z104301 | Z104301 | GABA-A Receptor; Anion Channel | 410 | 0.37 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 3020 | 0.32 | Binding ≤ 10μM |
PARC_STAAU | P0C1U9 | Topoisomerase IV Subunit A, Staau | 1000 | 0.35 | Binding ≤ 10μM |
GYRA_ECOLI | P0AES4 | DNA Gyrase Subunit A, Ecoli | 200 | 0.39 | Functional ≤ 10μM |
GYRB_ECOLI | P0AES6 | DNA Gyrase Subunit B, Ecoli | 200 | 0.39 | Functional ≤ 10μM |
Z50212 | Z50212 | Escherichia Coli | 0.1 | 0.58 | Functional ≤ 10μM |
Z50378 | Z50378 | Mycobacterium Intracellulare | 1056 | 0.35 | Functional ≤ 10μM |
Z50380 | Z50380 | Mycobacterium Smegmatis | 1070 | 0.35 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 1750 | 0.34 | Functional ≤ 10μM |
Z50117 | Z50117 | Pseudomonas Aeruginosa | 220 | 0.39 | Functional ≤ 10μM |
Z50185 | Z50185 | Staphylococcus Aureus | 1100 | 0.35 | Functional ≤ 10μM |
PARC_STAAU | P0C1U9 | Topoisomerase IV Subunit A, Staau | 2500 | 0.33 | Functional ≤ 10μM |
PARC_ECOLI | P0AFI2 | Topoisomerase IV Subunit A, Ecoli | 2500 | 0.33 | Functional ≤ 10μM |
Description | Species |
---|---|
G0 and Early G1 | |
Voltage gated Potassium channels |